You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphocytic, Chronic, B-Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Loncastuximab Tesirine
  • (no location specified)
Jul 24, 2023

Chronic Lymphocytic Leukemia Patients

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • San Francisco, California
      Power Life Sciences
    Jun 2, 2023

    Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • CC312
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 12, 2023

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
    • +6 more
    • (no location specified)
    Apr 12, 2023

    Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

    Completed
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Myeloma Coach or CLL Coach Mobile App
    • Springboard Beyond Cancer informational website
    • Durham, North Carolina
      Duke University
    Jun 23, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)

    Not yet recruiting
    • Lymphoproliferative Disorders
    • +3 more
    • No intervention
    • (no location specified)
    Jan 30, 2023

    Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    Jul 10, 2023

    Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

    Recruiting
    • CLL/SLL
    • Jinan, Shandong, China
      Department of Hematology, Shandong Provincial Hospital Affiliate
    Jun 16, 2023

    "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

    Recruiting
    • Mantle-cell Lymphoma
    • B Cell Chronic Lymphocytic Leukemia
      • Monza, MB, Italy
        Andrea Aroldi
      May 24, 2023

      Determination of Blood Tumor Cells

      Completed
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Abnormalities Cell Epithelial
        • Zurich, Switzerland
          University Hospital Zurich
        Jan 9, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • (no location specified)
        Nov 22, 2023

        Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

        Not yet recruiting
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • Zanubrutinib Pill
        • +2 more
        • New York, New York
          Weill Cornell Medicine/NewYork-Presberteryian Hospital
        Dec 6, 2022

        B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
          • Manhasset, New York
            Feinstein Institute for Medical Research
          Jul 6, 2022

          CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

          Not yet recruiting
          • CLL
          • (no location specified)
          Oct 3, 2023

          B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

          Not yet recruiting
          • B-cell Non Hodgkin Lymphoma
          • Chronic Lymphocytic Leukemia
          • Cyclophosphamide injection
          • +2 more
          • Charleston, South Carolina
            Hollings Cancer Center at Medical University of South Carolina
          Jan 18, 2023

          Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • +2 more
          • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Apr 10, 2023

          Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

          Active, not recruiting
          • Leukemia, Lymphocytic, Chronic, B-Cell
          • Lymphoma, Non-Hodgkin
          • Copenhagen, Denmark
          • +9 more
          Jan 27, 2023

          Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

          Not yet recruiting
          • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
            • (no location specified)
            Dec 16, 2022

            Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

            Recruiting
            • Follicular Lymphoma
            • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 20, 2023

            Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

            Not yet recruiting
            • Relapsed/Refractory Chronic Lymphocytic Leukemia
            • Tianjin, Tianjin, China
              Institute of Hematology and Blood Diseases Hospital, Chinese Aca
            Jul 13, 2023

            B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

            Not yet recruiting
            • Chronic Lymphocytic Leukemia
            • +4 more
            • Non-Interventional Study
            • Rochester, Minnesota
              Mayo Clinic in Rochester
            Nov 22, 2023